Whitehawk Therapeutics (WHWK) Free Cash Flow (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Free Cash Flow of -$22.2 million for Q1 2026, down 78.88% year-over-year from -$105.2 million in Q1 2025, and down 24.86% on a QoQ basis from -$17.8 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Free Cash Flow data on file, last reported at -$22.2 million in Q1 2026.
- Quarterly Free Cash Flow fell 78.88% year-over-year to -$22.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$107.8 million (down 104.41% YoY) and the FY2025 annual result came in at -$98.0 million, down 61.42% from the prior year.
- Free Cash Flow declined to -$22.2 million in Q1 2026 per WHWK's latest filing, from -$17.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$8.5 million in Q3 2022 and bottomed at -$52.4 million in Q2 2025.
- The 5-year median for Free Cash Flow is -$15.4 million (2025), against an average of -$17.3 million.
- The widest annual swing landed in 2024, when Free Cash Flow jumped 51.12%; it then plunged 481.71% in 2025.
- Tracing WHWK's Free Cash Flow over 5 years: stood at -$11.4 million in 2022, then slipped by 18.49% to -$13.5 million in 2023, then decreased by 9.22% to -$14.7 million in 2024, then dropped by 20.68% to -$17.8 million in 2025, then declined by 24.86% to -$22.2 million in 2026.
- Per Business Quant, the three latest WHWK Free Cash Flow figures stand at -$22.2 million (Q1 2026), -$17.8 million (Q4 2025), and -$15.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -22.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.21 Mn |
| Mar 31, 2026 | -22.21 Mn |
| Dec 31, 2025 | -17.79 Mn |
| Dec 31, 2025 | -17.79 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | -52.41 Mn |
| Jun 30, 2025 | -52.41 Mn |
| Mar 31, 2025 | -12.42 Mn |
| Mar 31, 2025 | -12.42 Mn |
| Dec 31, 2024 | -14.74 Mn |
| Dec 31, 2024 | -14.74 Mn |
| Sep 30, 2024 | -16.56 Mn |
| Sep 30, 2024 | -16.56 Mn |
| Jun 30, 2024 | -9.01 Mn |
| Jun 30, 2024 | -9.01 Mn |
| Mar 31, 2024 | -20.39 Mn |
| Mar 31, 2024 | -20.39 Mn |
| Dec 31, 2023 | -13.49 Mn |
| Dec 31, 2023 | -13.49 Mn |
| Sep 30, 2023 | -10.02 Mn |
| Sep 30, 2023 | -10.02 Mn |
| Jun 30, 2023 | -18.43 Mn |
| Jun 30, 2023 | -18.43 Mn |
| Mar 31, 2023 | -21.70 Mn |
| Mar 31, 2023 | -21.70 Mn |
| Dec 31, 2022 | -11.39 Mn |
| Dec 31, 2022 | -11.39 Mn |
| Sep 30, 2022 | -8.51 Mn |
| Sep 30, 2022 | -8.51 Mn |
| Jun 30, 2022 | -10.75 Mn |
| Jun 30, 2022 | -10.75 Mn |
| Mar 31, 2022 | -19.44 Mn |
| Mar 31, 2022 | -19.44 Mn |
| Dec 31, 2021 | -12.43 Mn |
| Dec 31, 2021 | -12.43 Mn |
| Sep 30, 2021 | -17.37 Mn |
| Sep 30, 2021 | -17.37 Mn |
| Jun 30, 2021 | -3.19 Mn |
| Jun 30, 2021 | -3.19 Mn |
| Mar 31, 2021 | 10.56 Mn |
| Mar 31, 2021 | 10.56 Mn |
| Dec 31, 2020 | -3.28 Mn |
| Dec 31, 2020 | -3.28 Mn |
| Sep 30, 2020 | -15.78 Mn |
| Sep 30, 2020 | -15.78 Mn |
| Jun 30, 2020 | 10.29 Mn |
| Jun 30, 2020 | 10.29 Mn |
| Mar 31, 2020 | -3.94 Mn |
| Mar 31, 2020 | -3.94 Mn |
| Dec 31, 2019 | -4.87 Mn |
| Dec 31, 2019 | -4.87 Mn |
| Sep 30, 2019 | -4.77 Mn |
| Sep 30, 2019 | -4.77 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Mar 31, 2019 | -9.19 Mn |
| Mar 31, 2019 | -9.19 Mn |
| Dec 31, 2018 | -6.19 Mn |
| Dec 31, 2018 | -6.19 Mn |
| Sep 30, 2018 | -6.24 Mn |
| Sep 30, 2018 | -6.24 Mn |
| Jun 30, 2018 | 13.11 Mn |
| Jun 30, 2018 | 13.11 Mn |
| Mar 31, 2018 | -6.52 Mn |
| Mar 31, 2018 | -6.52 Mn |
| Dec 31, 2017 | -4.61 Mn |
| Dec 31, 2017 | -4.61 Mn |
| Sep 30, 2017 | -4.02 Mn |
| Sep 30, 2017 | -4.02 Mn |
| Jun 30, 2017 | -6.33 Mn |
| Jun 30, 2017 | -6.33 Mn |
| Mar 31, 2017 | -3.93 Mn |
| Mar 31, 2017 | -3.93 Mn |
| Dec 31, 2016 | -3.04 Mn |
| Dec 31, 2016 | -3.04 Mn |
| Sep 30, 2016 | -4.83 Mn |
| Sep 30, 2016 | -4.83 Mn |
| Jun 30, 2016 | -3.98 Mn |
| Jun 30, 2016 | -3.98 Mn |
| Mar 31, 2016 | -3.98 Mn |
| Mar 31, 2016 | -3.98 Mn |
| Dec 31, 2015 | -2,741.00 |
| Dec 31, 2015 | -2,741.00 |
| Sep 30, 2015 | -3,825.00 |
| Sep 30, 2015 | -3,825.00 |
| Jun 30, 2015 | -13,192.00 |
| Jun 30, 2015 | -13,192.00 |
| Mar 31, 2015 | -1,976.00 |
| Mar 31, 2015 | -1,976.00 |
| Dec 31, 2014 | -12,604.00 |
| Dec 31, 2014 | -12,604.00 |
| Sep 30, 2014 | -1,701.00 |
| Sep 30, 2014 | -1,701.00 |
| Jun 30, 2014 | -1,315.00 |
| Jun 30, 2014 | -1,315.00 |
| Mar 31, 2014 | -400.00 |
| Mar 31, 2014 | -400.00 |
| Dec 31, 2013 | -4,012.00 |
| Dec 31, 2013 | -4,012.00 |
| Sep 30, 2013 | -8,125.00 |
| Sep 30, 2013 | -8,125.00 |
| Jun 30, 2013 | -9,286.00 |
| Jun 30, 2013 | -9,286.00 |
| Mar 31, 2013 | -1,901.00 |
| Mar 31, 2013 | -1,901.00 |
| Dec 31, 2012 | -784.00 |
| Dec 31, 2012 | -784.00 |
| Sep 30, 2012 | -3,920.00 |
| Sep 30, 2012 | -3,920.00 |
| Jun 30, 2012 | -14,287.00 |
| Jun 30, 2012 | -14,287.00 |
| Mar 31, 2012 | -5,527.00 |
| Mar 31, 2012 | -5,527.00 |
| Dec 31, 2011 | -2,005.00 |
| Dec 31, 2011 | -2,005.00 |
| Sep 30, 2011 | -3,100.00 |
| Sep 30, 2011 | -3,100.00 |
| Jun 30, 2011 | -15,404.00 |
| Jun 30, 2011 | -15,404.00 |
| Mar 31, 2011 | -2,264.00 |
| Mar 31, 2011 | -2,264.00 |
| Dec 31, 2010 | -356.00 |
| Dec 31, 2010 | -356.00 |
| Sep 30, 2010 | -3,506.00 |
| Sep 30, 2010 | -3,506.00 |